Walleye Capital’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-417,110
Closed -$68.3M 4894
2025
Q4
$68.3M Buy
417,110
+231,353
+125% +$36.2M 0.21% 33
2025
Q3
$24.8M Buy
185,757
+94,157
+103% +$11.4M 0.09% 191
2025
Q2
$11.4M Buy
91,600
+11,124
+14% +$1.42M 0.04% 442
2025
Q1
$10.2M Buy
80,476
+34,996
+77% +$5.39M 0.05% 438
2024
Q4
$6.55M Sell
45,480
-49,227
-52% -$7.06M 0.02% 902
2024
Q3
$14.1M Buy
94,707
+51,597
+120% +$7.4M 0.03% 510
2024
Q2
$5.43M Buy
43,110
+42,957
+28,076% +$6.73M 0.01% 1222
2024
Q1
$28.1K Buy
+153
New +$29.1K ﹤0.01% 4833
2023
Q3
Sell
-3,082
Closed -$504K 5250
2023
Q2
$436K Buy
+3,082
New +$494K ﹤0.01% 2541
2022
Q2
Sell
-2,305
Closed -$434K 2674
2022
Q1
$434K Buy
+2,305
New +$438K 0.01% 1088
2021
Q4
Sell
-1,414
Closed -$409 2275
2021
Q3
$409 Buy
1,414
+354
+33% +$90.8K 0.01% 876
2021
Q2
$212 Buy
+1,060
New +$206K 0.01% 1052
2021
Q1
Sell
-1,311
Closed -$251 1316
2020
Q4
$251 Buy
+1,311
New +$239K 0.02% 670
2019
Q4
Sell
-2,864
Closed -$241K 2193
2019
Q3
$220K Buy
2,864
+2,704
+1,690% +$237K 0.01% 1161
2019
Q2
$14K Buy
+160
New +$10.9K ﹤0.01% 1565

Other funds holding RGEN

Walleye Capital's RGEN Position: Q1 2026 in Review

Walleye Capital sold out of Repligen (RGEN) in Q1 2026, closing a stake of 417,110 shares — an estimated $68.3M sold.

Walleye Capital first reported a position in RGEN in Q2 2019 and held it in 15 quarters. The position peaked at $68.3M in Q4 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Walleye Capital reported no remaining Repligen position as of Q1 2026 after selling out during the quarter.
  • Walleye Capital sold 417,110 Repligen shares in Q1 2026, an estimated $68.3M.
  • Walleye Capital first reported a position in Repligen in Q2 2019 and held it in 15 quarters.
  • Walleye Capital's Repligen position peaked at $68.3M in Q4 2025.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.